ABSTRACT
INTRODUCTION: Hypertensive nephrosclerosis (HN) ranks as one of the most frequent causes of chronic kidney disease (CKD), but its very existence has repeatedly been called into question, especially in young adults. Its diagnostic framework is established chiefly on non-specific clinical criteria, and its defining histopathological set of features is in fact shared by numerous other conditions. Genetic testing based on exome sequencing (ES) has emerged as a comprehensive tool to detect Mendelian diseases in timely fashion in nephrology, with a significant number of re-established diagnoses. The aim of this study was to investigate the diagnostic yield of ES in patients with a clinical diagnosis of hypertensive nephropathy. METHOD: Since September 2018, ES has been readily available as part of the routine diagnostic work-up in our institution. The indication of ES includes hypertensive nephropathy of early onset (i.e., <45 years old). We retrospectively collected the ES data performed in the context of hypertensive nephropathy in our institution between September 2018 and February 2021. RESULTS: A total of 128 patients were sequenced in the context of hypertensive nephropathy with early onset. The chief indications of ES were an early onset of CKD (47%), family history of kidney disease (8%), or both (18%). We detected diagnostic variants in 19 of the 128 patients (15%), encompassing a total of 13 different monogenic disorders. The diagnostic yield of ES was lower in patients of African ancestry (diagnostic yield of 7 vs. 30% in non-African ancestry patients, p < 0.001). CONCLUSIONS: The high diagnostic yield of ES (15%) in a population of patients thought to have HN casts further doubts on the validity of the existing diagnosis criteria, including histological criteria, supposed to characterize the condition. This was especially true in patients with no African ancestry, where ES positivity reached 30%.
Subject(s)
Exome Sequencing , Hypertension, Renal , Humans , Male , Female , Adult , Middle Aged , Retrospective Studies , Hypertension, Renal/genetics , Hypertension, Renal/diagnosis , Age of Onset , Nephritis/genetics , Nephritis/diagnosis , Renal Insufficiency, Chronic/genetics , Renal Insufficiency, Chronic/diagnosis , Nephrosclerosis/genetics , Nephrosclerosis/diagnosisABSTRACT
OBJECTIVE: This study aimed to investigate the clinical value of the combination detection of captopril renal scintigraphy (CRS) and plasma renin activity (PRA) in the diagnosis of renal hypertension (RHR). METHODS: Retrospective analysis was conducted on the clinical data of 163 patients with suspected RHR admitted to our hospital from March 2019 to March 2021, and all patients underwent blood pressure, CRS and digital subtraction angiography (DSA). The patients were divided into the positive group (n = 100) and the negative group (n = 63) in accordance with the results of DSA examination. PRA, angiotensin II and aldosterone levels of the two groups were detected and compared. The receiver operating characteristic curve was used to analyse the CRS, PRA and combined diagnostic performance. RESULTS: The uptake ratio value after captopril intervention in the positive group was 36.71% ± 8.79%, which was significantly lower than that in the negative group (56.79% ± 10.09%, p < 0.05). The serum PRA level of the positive group was 4.70 ± 1.67 ng/mLêh, which was distinctly higher than that of the negative group (2.12 ± 1.03 ng/mLêh, p < 0.05). The sensitivity and Youden index under the combination detection (area under the curve (AUC) = 0.956, p < 0.001) were all higher than those under single detection. CONCLUSION: The combined detection of PRA and CRS can provide considerable evidence for the early diagnosis and treatment of RHR, which has a certain clinical value.
Subject(s)
Captopril , Hypertension, Renal , Renin , Humans , Blood Pressure , Captopril/therapeutic use , Hypertension, Renal/diagnosis , Radionuclide Imaging , Renin/blood , Retrospective StudiesABSTRACT
Systemic sclerosis (SSc) is an immune-mediated rheumatic disease characterized by vascular abnormalities, tissue fibrosis, and inflammation. Renal disease occurring in patients with SSc may have a variable clinicopathological picture. However, the most specific renal condition associated with this disease is the scleroderma renal crisis (SRC), characterized by acute onset of renal failure and severe hypertension. SRC develops in about 20% of cases of SSc, especially in those patients with diffuse cutaneous disease. The prognosis of this condition is often negative, with a rapid progression to end-stage renal disease (ESRD). The advent of the antihypertensive angiotensin-converting enzyme inhibitors in 1980 was associated with a significant improvement in patients' survival and recovery of renal function. However, the prognosis of these patients can still be improved. The dialytic condition is associated with early death, and mortality is significantly higher than among patients undergoing renal replacement therapy (RRT) due to other conditions. Patients with SRC who show no signs of renal functional recovery despite timely blood pressure control are candidates for kidney transplantation (KT). In this review, we reported the most recent advances in KT in patients with ESRD due to SSc, with a particular overview of the risk of disease recurrence after transplantation and the evolution of other disease manifestations.
Subject(s)
Acute Kidney Injury , Hypertension, Renal , Kidney Failure, Chronic , Kidney Transplantation , Scleroderma, Localized , Scleroderma, Systemic , Acute Kidney Injury/therapy , Humans , Hypertension, Renal/complications , Hypertension, Renal/diagnosis , Hypertension, Renal/therapy , Kidney Failure, Chronic/complications , Kidney Failure, Chronic/surgery , Kidney Transplantation/adverse effects , Scleroderma, Systemic/complications , Scleroderma, Systemic/pathology , Scleroderma, Systemic/therapySubject(s)
Adenocarcinoma/diagnosis , Kidney/diagnostic imaging , Rectal Neoplasms/diagnosis , Adenocarcinoma/complications , Constipation/etiology , Female , Humans , Hypertension, Renal/diagnosis , Hypertension, Renal/etiology , Kidney/metabolism , Kidney/pathology , Rectal Neoplasms/complications , Renin/metabolism , Young AdultABSTRACT
BACKGROUND: Page kidney is a rare condition leading to secondary hypertension and encountered most frequently due to traumatic subcapsular hematoma. Here, we present a case of a 15-year-old boy with a history of Tourette syndrome, who had Page kidney hypertension secondary to subcapsular hematoma compression due to his self-injury behavior for many years.
Subject(s)
Hematoma/etiology , Hypertension, Renal/etiology , Self-Injurious Behavior/complications , Tourette Syndrome/complications , Adolescent , Antihypertensive Agents/therapeutic use , Drainage , Hematoma/diagnosis , Hematoma/therapy , Humans , Hypertension, Renal/diagnosis , Hypertension, Renal/drug therapy , Hypertension, Renal/physiopathology , Male , Self-Injurious Behavior/diagnosis , Self-Injurious Behavior/psychology , Tourette Syndrome/diagnosis , Tourette Syndrome/psychology , Treatment OutcomeABSTRACT
BACKGROUND: The association of hypertension with congenital renal hypoplasia has been established. We report a case of an infant who underwent nephrectomy for hypertension. CASE PRESENTATION: Magnetic resonance imaging for the mother revealed fetal renal masses, and fetal multicystic dysplastic kidney was suspected. Following birth, the baby developed hypertension. Numerous investigations revealed that the left kidney was non-functional, and she was initiated on benazepril hydrochloride. However, because the drug response was poor, the left kidney was removed at the age of 7 months. Examination of the renal specimen revealed abrupt transition from normal to atrophic cortex with lobar atrophy and cysts. Tubular atrophy, marked abnormal blood vessels with wall thickening, gathered immature glomeruli, and parenchymal destruction were observed. Renin was partially localized in the proximal tubules and the parietal epithelium of the Bowman's capsule in the immature glomeruli. We speculated that an abnormal vascular structure and irregular renin localizations may be the cause of hypertension. Serum renin and aldosterone levels gradually reduced post-surgery, reaching normal levels on the 90th postoperative day. A long follow-up is needed due to the possibility of the child developing hypertension in the future. CONCLUSION: This is a case of an infant with MCDK, which discusses the clinicopathological features based on the pathophysiological analysis, including renin evaluation.
Subject(s)
Hypertension, Renal/diagnosis , Multicystic Dysplastic Kidney/diagnosis , Female , Humans , Hypertension, Renal/etiology , Hypertension, Renal/physiopathology , Infant , Multicystic Dysplastic Kidney/complications , Multicystic Dysplastic Kidney/physiopathologyABSTRACT
BACKGROUND: Hypertensive nephrosclerosis is the presumed underlying cause in many end-stage kidney disease (ESKD) patients, but the diagnosis is disputed and based on clinical criteria with low diagnostic accuracy. OBJECTIVE: To evaluate and improve the diagnostic process for nephrosclerosis patients. METHODS: We included adults from the population-based HUNT study (n = 50 552), Norwegian CKD patients referred for kidney biopsy 1988-2012 (n = 7261), and unselected nephrology clinic patients (n = 193) used for matching. Decision tree analysis and ROC curve-based methods of optimal cut-offs were used to improve clinical nephrosclerosis criteria. RESULTS: Nephrosclerosis prevalence was 2.7% in the general population, and eGFR decline and risk for kidney-related hospital admissions and ESKD were comparable to patients with diabetic kidney disease. In the biopsy cohort, current clinical criteria had very low sensitivity (0.13) but high specificity (0.94) for biopsy-verified arterionephrosclerosis. A new optimized diagnostic algorithm based on proteinuria (<0.75 g d-1 ), systolic blood pressure (>155 mm Hg) and age (>75 years) only marginally improved diagnostic accuracy (sensitivity 0.19, specificity 0.96). Likewise, there were still false-positive cases with treatable diagnoses like glomerulonephritis, interstitial nephritis and others (40% of all test positive). Decision curve analysis showed that the new criteria can lead to higher clinical utility, especially for patients considering the potential harms to be close to the potential benefits, while the more risk-tolerant ones (harm:benefit ratio < 1:4) should consider kidney biopsy. CONCLUSION: Further improvements of the current clinical criteria seem difficult, so risks and benefits of kidney biopsy could be more actively discussed with selected patients to reduce misclassification and direct treatment.
Subject(s)
Hypertension, Renal/pathology , Kidney/pathology , Nephritis/pathology , Nephrosclerosis/pathology , Biopsy , Decision Trees , Glomerular Filtration Rate , Humans , Hypertension, Renal/complications , Hypertension, Renal/diagnosis , Hypertension, Renal/epidemiology , Kidney Failure, Chronic/etiology , Middle Aged , Nephritis/complications , Nephritis/diagnosis , Nephritis/epidemiology , Nephrosclerosis/complications , Nephrosclerosis/diagnosis , Nephrosclerosis/epidemiology , Norway/epidemiology , Prevalence , Prognosis , ROC Curve , Sensitivity and Specificity , Survival AnalysisABSTRACT
BACKGROUND: Patients with flank pain and hematuria are common emergency department presentations of nephrolithiasis. We may anchor on this etiology and potentially miss other less common differentials. We present a case of a patient with hematuria and flank pain typical of nephrolithiasis who was diagnosed with a Page kidney causing secondary hypertension. A 50 year-old male with no significant past medical history presented to the Emergency Department with severe left-sided flank pain, vomiting, and blood-tinged urine. We pursued a diagnosis of nephrolithiasis and found a left renal subcapsular hematoma on non-contrast CT. A CTA was done with no active hemorrhage found. The patient had no history of recent trauma and was found to be hypertensive on evaluation. Urology was consulted and management for the patient's hypertension was initiated. He was diagnosed with Page Kidney and admitted to medicine for observation and hypertension management with an angiotensin-converting enzyme inhibitor. Page Kidney is a diagnosis that describes compression of the renal parenchyma by a hematoma or mass causing secondary hypertension through the activation of the renin-angiotensin-aldosterone system. Causes may include traumatic subcapsular hematoma, renal cyst rupture, tumor, hemorrhage, arteriovenous malformation, among others. Treatment may involve conservative measures including hypertension management, or more invasive measures like evacuation or nephrectomy. We describe the case of a patient presumed to have nephrolithiasis presenting with typical left-sided flank pain, diagnosed with Page kidney, and treated conservatively.
Subject(s)
Hypertension, Renal/diagnosis , Nephritis/diagnosis , Angiotensin-Converting Enzyme Inhibitors/therapeutic use , Diagnosis, Differential , Flank Pain , Hematuria , Humans , Hypertension, Renal/drug therapy , Kidney Calculi/diagnosis , Male , Middle Aged , Nephritis/drug therapyABSTRACT
Blood pressure (BP) is characterized by spontaneous oscillation over time, which is described as BP variability (BPV). The current study aimed to investigate whether short-term BPV was correlated with hypertensive nephropathy in Han Chinese individuals with hypertension. A single-center prospective cohort study of 300 Han Chinese participants with hypertension was conducted in Taiwan. Five different BPV parameters were derived from ambulatory BP monitoring (ABPM), including standard deviation (SD), weighted SD (wSD), coefficient of variation (CoV), successive variation (SV), and average real variability (ARV). Renal event was defined as > 50% reduction in baseline estimated glomerular filtration rate (eGFR). The average age of the participants was 63.5 years. The baseline eGFR was 84.5 mL/min/1.73 m2 . The participants were divided into two groups according to the wSD of systolic BP (SBP). Survival was assessed via a Kaplan-Meier analysis. During the 4.2-year follow-up, the participants with the highest SBP wSD tertile had a greater number of renal events (6.0%) than their counterparts (0.5%) (log-rank test, p = .007). The Cox proportional hazard regression model was used to assess the independent effects of BPV, and results showed that 24-h SBP (HR = 1.105; 95% CI = 1.020-1.197, p = .015) and 24-h DBP (HR = 1.162; 95% CI = 1.004-1.344, p = .044) were independently associated with renal events. However, BPV parameters were only associated with renal events univariately, but not after adjusting for baseline characteristics, 24-h mean BP, and office BP. Therefore, the risk of hypertensive nephropathy was independently associated with 24-h mean BP, but not with ambulatory BPV, in Han Chinese participants with hypertension.
Subject(s)
Blood Pressure Monitoring, Ambulatory/methods , Blood Pressure/physiology , Hypertension, Renal/diagnosis , Hypertension/physiopathology , Nephritis/diagnosis , Aged , Aged, 80 and over , Antihypertensive Agents/adverse effects , Antihypertensive Agents/therapeutic use , Asian People/ethnology , Blood Pressure/drug effects , Blood Pressure Monitoring, Ambulatory/statistics & numerical data , Glomerular Filtration Rate/physiology , Humans , Hypertension/complications , Hypertension/drug therapy , Hypertension, Renal/physiopathology , Middle Aged , Nephritis/physiopathology , Prospective Studies , Risk Assessment , Taiwan/epidemiologyABSTRACT
Although disturbed phosphate metabolism frequently accompanies chronic kidney disease (CKD), its causal role in CKD progression remains unclear. It is also not fully understood how excess salt induces organ damage. We here show that urinary phosphate-containing nanoparticles promote kidney injury in salt-sensitive hypertension. In Dahl salt-sensitive rats, salt loading resulted in a significant increase in urinary phosphate excretion without altering serum phosphate levels. An intestinal phosphate binder sucroferric oxyhydroxide attenuated renal inflammation and proteinuria in this model, along with the suppression of phosphaturia. Using cultured proximal tubule cells, we confirmed direct pathogenic roles of phosphate-containing nanoparticles in renal tubules. Finally, transcriptome analysis revealed a potential role of complement C1q in renal inflammation associated with altered phosphate metabolism. These data demonstrate that increased phosphate excretion promotes renal inflammation in salt-sensitive hypertension and suggest a role of disturbed phosphate metabolism in the pathophysiology of hypertensive kidney disease and high salt-induced kidney injury.
Subject(s)
Hypertension, Renal/etiology , Hypertension, Renal/urine , Nanoparticles , Nephritis/etiology , Nephritis/urine , Phosphates/urine , Animals , Biomarkers , Cardiomegaly/etiology , Cardiomegaly/metabolism , Cardiomegaly/pathology , Chemokine CCL2/genetics , Chemokine CCL2/metabolism , Disease Models, Animal , Fluorescent Antibody Technique , Gene Expression Profiling , Gene Expression Regulation , Glomerulonephritis/diagnosis , Glomerulonephritis/etiology , Glomerulonephritis/urine , Hypertension, Renal/diagnosis , Hypertension, Renal/metabolism , Immunohistochemistry , Macrophages/immunology , Macrophages/metabolism , Macrophages/pathology , Models, Biological , Nanoparticles/chemistry , Nephritis/diagnosis , Nephritis/metabolism , Phosphates/blood , Phosphates/chemistry , Rats , Rats, Inbred Dahl , Transcriptome , UrinalysisSubject(s)
Antihypertensive Agents/administration & dosage , Biopsy/adverse effects , Drainage/methods , Flank Pain , Hematoma , Hypertension, Renal , Kidney , Postoperative Hemorrhage , Adult , Biopsy/methods , Decompression, Surgical/methods , Diagnosis, Differential , Flank Pain/diagnosis , Flank Pain/etiology , Hematoma/etiology , Hematoma/physiopathology , Humans , Hypertension, Renal/diagnosis , Hypertension, Renal/etiology , Hypertension, Renal/metabolism , Hypertension, Renal/therapy , Kidney/diagnostic imaging , Kidney/metabolism , Kidney/pathology , Kidney/physiopathology , Male , Metabolism , Postoperative Hemorrhage/physiopathology , Renin-Angiotensin System , Tomography, X-Ray Computed/methodsABSTRACT
OBJECTIVES: To investigate the effect of ACE inhibitors (ACEi) on the incidence of scleroderma renal crisis (SRC) when given prior to SRC in the prospectively collected cohort from the European Scleroderma Trial and Research Group (EUSTAR). METHODS: SSc patients without prior SRC and at least one follow-up visit were included and analyzed regarding SRC, arterial hypertension, and medication focusing on antihypertensive medication and glucocorticoids (GC). RESULTS: Out of 14,524 patients in the database, we identified 7648 patients with at least one follow-up. In 27,450 person-years (py), 102 patients developed SRC representing an incidence of 3.72 (3.06-4.51) per 1000 py. In a multivariable time-to-event analysis adjusted for age, sex, disease severity, and onset, 88 of 6521 patients developed SRC. The use of ACEi displayed an increased risk for the development of SRC with a hazard ratio (HR) of 2.55 (95% confidence interval (CI) 1.65-3.95). Adjusting for arterial hypertension resulted in a HR of 2.04 (95%CI 1.29-3.24). There was no evidence for an interaction of ACEi and arterial hypertension (HR 0.83, 95%CI 0.32-2.13, p = 0.69). Calcium channel blockers (CCB), angiotensin receptor blockers (ARB), endothelin receptor antagonists, and GC-mostly in daily dosages below 15 mg of prednisolone-did not influence the hazard for SRC. CONCLUSIONS: ACEi in SSc patients with concomitant arterial hypertension display an independent risk factor for the development of SRC but are still first choice in SRC treatment. ARBs might be a safe alternative, yet the overall safety of alternative antihypertensive drugs in SSc patients needs to be further studied.
Subject(s)
Acute Kidney Injury/diagnosis , Angiotensin-Converting Enzyme Inhibitors/therapeutic use , Hypertension, Renal/diagnosis , Scleroderma, Systemic/drug therapy , Acute Kidney Injury/epidemiology , Aged , Europe/epidemiology , Female , Humans , Hypertension, Renal/epidemiology , Incidence , Male , Middle Aged , Population Surveillance/methods , Prospective Studies , Risk Factors , Treatment OutcomeABSTRACT
This was an unusual case of a large renal artery pseudoaneurysm with impending rupture, which was successfully treated with an endovascular stent-graft in a solitary kidney.
Subject(s)
Aneurysm, False , Angiography/methods , Blood Vessel Prosthesis Implantation , Endovascular Procedures/methods , Renal Artery , Solitary Kidney/diagnostic imaging , Tomography, X-Ray Computed/methods , Abdominal Pain/diagnosis , Adult , Aneurysm, False/diagnosis , Aneurysm, False/physiopathology , Aneurysm, False/surgery , Blood Vessel Prosthesis Implantation/instrumentation , Blood Vessel Prosthesis Implantation/methods , Female , Humans , Hypertension, Renal/diagnosis , Hypertension, Renal/therapy , Renal Artery/diagnostic imaging , Renal Artery/pathology , Renal Artery/surgery , Stents , Treatment OutcomeABSTRACT
BACKGROUND: Despite the abundance of data documenting the consequences of poor sleep quality on blood pressure (BP), no previous study to our knowledge has addressed the impact of sleep improvement on resistant hypertension among patients with chronic kidney disease (CKD). METHODS: The aim of this pilot study was to determine whether improved sleep quality and duration will improve BP control in patients with resistant hypertension and CKD. It was a prospective single-center cohort study that involved 30 hypertensive subjects with CKD presenting with primary resistant hypertension and poor sleep quality or duration <6 h/night. Sleep quality and duration were modified using either sleep hygiene education alone or adding sleep medication. The cohort's BP was followed every 3 months for 6-month duration. The average home and clinic BPs were collected at each follow-up visit. The primary outcome baseline change in systolic BP (SBP) and diastolic BP (DBP; home and clinic) at 3 and 6 months after documented sleep improvement. Secondary outcomes included change from baseline in mean arterial pressure, and delta SBP after sleep improvement. RESULTS: African American patients represented 50% of the cohort. All patients had evidence of CKD with GFR ≤60 mL/min and were obese with 40% having type 2 diabetes mellitus. The primary endpoint of change in clinic SBP and DBP was significantly reduced at 3 months, baseline 156 ± 15/88 ± 8 vs. 3 months 125 ± 14/73 ± 7 (p < 0.0001). This difference persisted at 6 months. However, there was no further reduction in-home or clinic BPs between the 3- and 6-month periods. Home and clinic average delta SBP change at 3 months from baseline was -34.4 ± 15 and -30.8 ± 19 mm Hg respectively. Delta SBP change was associated with sleep improvement of >6 h/night, that is, gaining an extra 3-4 h' sleep duration, home; R2 = 0.66, p < 0.0001 and clinic; R2 = 0.49, p < 0.0001. CONCLUSION: Optimizing sleep quality and duration to >6 h/night improved BP control and was associated with a significant delta change in SBP within 3 months of follow-up. Physicians should obtain a sleep history in patients with CKD who present with resistant hypertension.
Subject(s)
Antihypertensive Agents/pharmacology , Blood Pressure/physiology , Hypertension, Renal/rehabilitation , Renal Insufficiency, Chronic/complications , Sleep/physiology , Adult , Aged , Antihypertensive Agents/therapeutic use , Blood Pressure Monitoring, Ambulatory , Drug Resistance , Female , Humans , Hypertension, Renal/diagnosis , Hypertension, Renal/drug therapy , Hypertension, Renal/etiology , Male , Middle Aged , Pilot Projects , Prospective Studies , Renal Insufficiency, Chronic/physiopathology , Renal Insufficiency, Chronic/rehabilitation , Risk Factors , Time Factors , Treatment OutcomeABSTRACT
Renovascular disease (RVD) is a major cause of secondary hypertension. Atherosclerotic renal artery stenosis is the most common type of RVD followed by fibromuscular dysplasia. It has long been recognized as the prototype of angiotensin-dependent hypertension. However, the mechanisms underlying the physiopathology of hypertensive occlusive vascular renal disease are complex and distinction between the different causes of RVD should be made. Recognition of these distinct types of RVD with different degrees of renal occlusive disease is important for management. The greatest challenge is to individualize and implement the best approach for each patient in the setting of widely different comorbidities.
Subject(s)
Fibromuscular Dysplasia , Hypertension, Renal , Hypertension, Renovascular , Nephritis , Renal Artery Obstruction , Fibromuscular Dysplasia/complications , Fibromuscular Dysplasia/diagnosis , Fibromuscular Dysplasia/physiopathology , Fibromuscular Dysplasia/therapy , Humans , Hypertension, Renal/diagnosis , Hypertension, Renal/etiology , Hypertension, Renal/physiopathology , Hypertension, Renal/therapy , Hypertension, Renovascular/diagnosis , Hypertension, Renovascular/etiology , Hypertension, Renovascular/physiopathology , Hypertension, Renovascular/therapy , Nephritis/diagnosis , Nephritis/etiology , Nephritis/physiopathology , Nephritis/therapy , Renal Artery Obstruction/complications , Renal Artery Obstruction/diagnosis , Renal Artery Obstruction/physiopathology , Renal Artery Obstruction/therapyABSTRACT
The effect of renal artery angioplasty on blood pressure in patients with true resistant hypertension and atherosclerotic renal artery stenosis has not been fully investigated due to the exclusion of these patients from most trials. In this study, we assessed the benefits of renal angioplasty on daytime ambulatory blood pressure (dABP) in this subgroup of patients. Medical records of our hypertension department were retrospectively analyzed from 2000 to 2016. Seventy-two patients were identified with resistant hypertension (dABP >135 or 85 mm Hg despite at least 3 antihypertensive drugs, including a diuretic) and atherosclerotic renal artery stenosis treated by angioplasty. Atherosclerotic renal artery stenosis was unilateral in 57 patients and bilateral in 15 patients. The mean age of the patients was 67.8±11.2 years; dABP was 157±16/82±10 mm Hg despite 4.0±1.0 antihypertensive treatments; estimated glomerular filtration rate was 52 (41-63) mL/min. After renal angioplasty, dABPM decreased by 14.0±17.3/6.4±8.7 mm Hg (P<0.001 for both), and the number of antihypertensive treatments decreased to 3.6±1.4 (P=0.002) with no significant change in estimated glomerular filtration rate. A high baseline systolic dABP and a low body mass index were independent predictors of systolic dABP changes. The decrease in dABP was confirmed in a subgroup of patients at one and 3 years of follow-up (N=31 and N=18 respectively, P≤0.001 for systolic and diastolic blood pressure at both visits). In this retrospective uncontrolled single-center study, angioplasty in patients with atherosclerotic renal artery stenosis and with true resistant hypertension significantly decreased dABP, reducing the need for antihypertensive treatment with no change in estimated glomerular filtration rate.
Subject(s)
Angioplasty, Balloon/methods , Blood Pressure Monitoring, Ambulatory/methods , Hypertension, Renal/diagnosis , Renal Artery Obstruction/surgery , Aged , Atherosclerosis/complications , Atherosclerosis/diagnosis , Cohort Studies , Databases, Factual , Female , Follow-Up Studies , France , Hospitals, University , Humans , Hypertension, Renal/etiology , Hypertension, Renal/surgery , Male , Middle Aged , Recurrence , Renal Artery Obstruction/diagnostic imaging , Renal Artery Obstruction/etiology , Retrospective Studies , Risk Assessment , Stents , Treatment Outcome , Ultrasonography, DopplerABSTRACT
PURPOSE: To identify the epidemiology and pathological types of kidney diseases and their changes during the past decade, in a population from Northeast China. METHODS: We retrospectively analysed clinical and renal pathological data from 4910 patients who received renal biopsies in the Second Hospital of Jilin University from 2008 to 2017. RESULTS: Males received more renal biopsies than females (p < 0.001). The average age (p < 0.001) and percentage of elderly patients (p < 0.001) increased over time. The pathological types were primary glomerulonephritis (PGN, 73.2%), secondary glomerulonephritis (SGN, 23.7%), tubular-interstitial nephropathy (TIN, 2.8%), and hereditary nephropathy (HN, 0.3%). The most common forms of PGN were membranous nephropathy (MN, 37.2%) and IgA nephropathy (IgAN, 29.9%). Over time, the prevalence of IgAN decreased, but the prevalence of MN increased. MN was more common in middle-aged and elderly patients, but IgAN was most common in young adults. Analysis of SGN data indicated that lupus nephritis (LN, 34.0%), Henoch-Schönlein purpura glomerulonephritis (HSPN, 17.9%), and diabetic nephropathy (DN, 11.7%) were the most common forms. Over time, the prevalence of DN (p = 0.003), hypertension-associated renal damage (p = 0.005), and systemic vasculitis-associated nephritis (SVARD, p < 0.001) increased, but the prevalence of HSPN (p < 0.001) and hepatitis B virus-associated glomerulonephritis (HBV-GN, p = 0.001) decreased. Nephrotic syndrome was the main clinical manifestation of PGN. CONCLUSION: From 2008 to 2017, renal biopsies were increasingly performed in the elderly. There were notable changes in the epidemiology and pathological types of kidney disease among renal biopsy patients at our centre.
Subject(s)
Biopsy , Glomerulonephritis/epidemiology , Hypertension, Renal/epidemiology , Nephritis, Hereditary/epidemiology , Adolescent , Adult , Aged , Aged, 80 and over , Child , Diabetic Nephropathies/diagnosis , Diabetic Nephropathies/epidemiology , Diabetic Nephropathies/pathology , Female , Glomerulonephritis/diagnosis , Glomerulonephritis/pathology , Glomerulonephritis, IGA/diagnosis , Glomerulonephritis, IGA/epidemiology , Glomerulonephritis, IGA/pathology , Glomerulonephritis, Membranous/diagnosis , Glomerulonephritis, Membranous/epidemiology , Glomerulonephritis, Membranous/pathology , Humans , Hypertension, Renal/diagnosis , Hypertension, Renal/pathology , Kidney/pathology , Male , Middle Aged , Nephritis, Hereditary/diagnosis , Nephritis, Hereditary/pathology , Young AdultABSTRACT
BACKGROUND: An overweight person is at high risk for hypertensive renal damage. The effect of weight on the association between systolic blood pressure (SBP) and albuminuria remains unknown in patients with histologically diagnosed hypertensive nephrosclerosis. METHODS: A total of 97 patients with biopsy-confirmed hypertensive nephrosclerosis were recruited from 13 centers throughout Japan. We examined the relationship between SBP and proteinuria among those who were overweight, which is defined as a body mass index ≥25 kg/m2, and those who were not. We examined the interaction of weight and SBP with albuminuria at baseline and with the changes in estimated glomerular filtration rate (eGFR) during the observational period. RESULTS: Our results included mean age (54 years old), blood pressure (138/80), eGFR (53 ml/min/1.73 m2), and urine albumin levels (0.2 g/day). SBP was significantly correlated with log-transformed urine albumin levels (r = 0.4, P = 0.01) in patients who were overweight (n = 38) compared with patients who were not overweight (n = 59). Multiple regression analysis revealed that the interaction between being overweight and SBP with respect to albuminuria was significantly correlated with the log-transformed urine albumin level (ß = 0.39, P = 0.047) and was independent of age, sex, and potential confounding factors. The interaction between weight and SBP ≥140 mm Hg was significantly associated with a greater decrease in eGFR in the following 3 years. CONCLUSIONS: Being overweight may enhance susceptibility to hypertensive glomerular damage and may eventually lead to renal progression in patients with hypertensive nephrosclerosis.